| Pulmonary hemorrhage after percutaneous coronary intervention with abciximab therapy. | |
| | |
MedLine Citation:
|
PMID: 12479522 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Abciximab has a key role in the treatment of patients with acute coronary syndromes undergoing percutaneous coronary intervention; however, an increased risk of bleeding complications is well recognized. We report a case of serious pulmonary hemorrhage after use of abciximab therapy. A definitive indication and treatment guideline should be available to minimize serious bleeding complications. Additionally, respiratory symptoms should be monitored closely for early detection of serious pulmonary hemorrhage in patients receiving abciximab therapy during percutaneous coronary intervention. |
| | |
Authors:
|
Rak Kyeong Choi; Nae Hee Lee; Dal Soo Lim; Suk keun Hong; Hweung Kon Hwang |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Mayo Clinic proceedings. Mayo Clinic Volume: 77 ISSN: 0025-6196 ISO Abbreviation: Mayo Clin. Proc. Publication Date: 2002 Dec |
Date Detail:
|
Created Date: 2002-12-13 Completed Date: 2003-01-02 Revised Date: 2013-05-24 |
Medline Journal Info:
|
Nlm Unique ID: 0405543 Medline TA: Mayo Clin Proc Country: United States |
Other Details:
|
Languages: eng Pagination: 1340-3 Citation Subset: AIM; IM |
Affiliation:
|
Yoorimbin@hanmail.net |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Antibodies, Monoclonal / adverse effects* Female Hemorrhage / chemically induced*, radiography Humans Immunoglobulin Fab Fragments / adverse effects* Lung Diseases / chemically induced*, radiography Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors* |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/Immunoglobulin Fab Fragments; 0/Platelet Glycoprotein GPIIb-IIIa Complex; X85G7936GV/abciximab |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Management of persistent symptoms in patients with asthma.
Next Document: Combined tracheal and esophageal stenting for palliation of tracheoesophageal symptoms from mediasti...